Both extracellular immunoglobin-like domains of CD80 contain residues critical for binding T cell surface receptors CTLA-4 and CD28 - Test2 - elhamkhani - TriplyDB

Both extracellular immunoglobin-like domains of CD80 contain residues critical for binding T cell surface receptors CTLA-4 and CD28

Both extracellular immunoglobin-like domains of CD80 contain residues critical for binding T cell surface receptors CTLA-4 and CD28

http://www.wikidata.org/entity/Q28288428

about

CD80 and CD86 are not equivalent in their ability to induce the tyrosine phosphorylation of CD28 Genetic Susceptibility to Vitiligo: GWAS Approaches for Identifying Vitiligo Susceptibility Genes and Loci The programmed death-1 immune-suppressive pathway: barrier to antitumor immunity Current aspects of vitiligo genetics Crystal structure of the receptor-binding domain of human B7-2: Insights into organization and signaling Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo Moraxella catarrhalis adhesin UspA1-derived recombinant fragment rD-7 induces monocyte differentiation to CD14+CD206+ phenotype CD28/CTLA-4 and CD80/CD86 families: signaling and function.The role of B7 costimulation in T-cell immunity.Incorporation of porcine adenovirus 4 fiber protein enhances infectivity of adenovirus vector on dendritic cells: implications for immune-mediated cancer therapy.Novel strategies for inhibiting PD-1 pathway-mediated immune suppression while simultaneously delivering activating signals to tumor-reactive T cells.Metastasis Suppressors Regulate the Tumor Microenvironment by Blocking Recruitment of Prometastatic Tumor-Associated Macrophages.B7DC/PDL2 promotes tumor immunity by a PD-1-independent mechanism.CTLA-4-B7 interaction is sufficient to costimulate T cell clonal expansion.Meta-analysis of cell- specific transcriptomic data using fuzzy c-means clustering discovers versatile viral responsive genes.Distinct transcriptional control in major immunogenetic subsets of chronic lymphocytic leukemia exhibiting subset-biased global DNA methylation profiles.Efficient subgroup C avian sarcoma and leukosis virus receptor activity requires the IgV domain of the Tvc receptor and proper display on the cell membrane Phylogenetic Gaussian process model for the inference of functionally important regions in protein tertiary structures.Altered expression of major immune regulatory molecules in peripheral blood immune cells associated with breast cancer.Update on novel monoclonal antibodies and immunoconjugates for the treatment of lymphoproliferative disorders.Non-glycosylated human B7-1(CD80) retains the capacity to bind its counter-receptors.Molecular targets on B-cells to prevent and treat antibody-mediated rejection in organ transplantation. Present and Future.Macrophages behavior on different NIPAm-based thermoresponsive substrates.Soluble CD80 restores T cell activation and overcomes tumor cell programmed death ligand 1-mediated immune suppression.Chimeric co-stimulatory molecules that selectively act through CD28 or CTLA-4 on human T cells.CD28: a signalling perspective.The amino-terminal immunoglobulin-like domain of activated leukocyte cell adhesion molecule binds specifically to the membrane-proximal scavenger receptor cysteine-rich domain of CD6 with a 1:1 stoichiometry.CTLA-4, a negative regulator of T-lymphocyte activation.IFN-γ alters the expression of diverse immunity related genes in a cell culture model designed to represent maturing neutrophils.B7.1 expression by the weakly immunogenic F98 rat glioma does not enhance immunogenicity.Interaction of CD80 with Neph1: a potential mechanism of podocyte injury.CD2 and the nature of protein interactions mediating cell-cell recognition.Human Soluble CD80 is generated by alternative splicing, and recombinant soluble CD80 binds to CD28 and CD152 influencing T-cell activation

P2860

Q22008700-279CF81D-2455-4D20-8A8A-26942F737F3D Q26766384-A8BE3753-8B45-4B8E-8AF6-A8378A14C2A0 Q26829847-4705E477-3BEA-40DE-8DE1-F025E89B7CE8 Q27003993-98C5BAB5-98A5-4AD0-969A-09E9F9C7E18E Q27640589-BA7F7CD4-423C-4D2C-879B-4FCDB20C6644 Q28924362-37B08ECD-7542-4D2D-B86D-B30115551C41 Q31153140-DDFC7166-245C-43B3-B5E6-E12D371FB943 Q33664107-E98B43A5-59CE-4863-B674-6CCC73C13F09 Q33717482-BF9D26F7-0998-43CC-8A60-BE47C13331A0 Q35620238-F4A39BEB-3B08-4D9A-8510-690626C57AC6 Q36021225-2503DDD9-CAA5-40BD-9E59-B6E450A1FDE7 Q36118028-F791D743-F197-4C9A-B5F4-18CD970F8D91 Q36370918-B5FC1641-5678-47A5-9921-86DD9ADBB2C0 Q36377088-E36F0E18-E83A-4B1F-9B2A-CE59AD9EE1FB Q36394312-5714A2C8-A741-40C2-95F3-1C988C0F0082 Q36484147-F42DE293-7AB0-4481-AC42-7937A6483C3F Q36949793-0E28A8C0-EFEF-4363-9888-1390F570AFB8 Q37487949-B6CAC633-B8E0-481C-9AB8-0A2361463CFE Q37562562-6C387386-3167-41D0-B95A-2B81109D3F19 Q37913356-33A88E62-E80B-47C5-9E3A-7D4CF63CADFD Q38335760-A452722B-9AA5-4D1F-9562-8D76268C77D9 Q38676578-28C3BB38-9177-4C23-AC3B-058CB6DB6483 Q39096887-279CF661-031F-4935-BF53-0B510ACD9390 Q39114787-8A8E7B01-2F25-4AE6-BF68-67A3F1446987 Q40712115-29D36F5D-69BD-450E-8E18-2D7FB5CE3C63 Q41113501-FF752222-2463-4422-BD3F-C930123D903B Q41183840-1374C941-7ED4-4BBD-9874-B2B1A97EA237 Q41332143-34FDF39E-A02E-4DD9-A1AB-80C44C393B18 Q42370805-D84B3384-579E-4153-A123-43E9D90DCB20 Q45868892-6E6557A1-9894-440A-BDA0-67796433497A Q47664775-0C6CFE25-61B3-459B-9B2C-2B0BEDE554E9 Q47699998-F300FB02-2197-4F8A-87A9-28CBF334B942 Q56901080-6D03F661-25C4-48B8-8FCB-391575C318E3

P2860

Both extracellular immunoglobin-like domains of CD80 contain residues critical for binding T cell surface receptors CTLA-4 and CD28

http://www.wikidata.org/entity/Q28288428

description

1995 nî lūn-bûn

@nan

1995 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

1995 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

1995年の論文

@ja

1995年論文

@yue

1995年論文

@zh-hant

1995年論文

@zh-hk

1995年論文

@zh-mo

1995年論文

@zh-tw

1995年论文

@wuu

name

Both extracellular immunoglobi ...... face receptors CTLA-4 and CD28

@ast

Both extracellular immunoglobi ...... face receptors CTLA-4 and CD28

@en

Both extracellular immunoglobi ...... face receptors CTLA-4 and CD28

@nl

type

label

Both extracellular immunoglobi ...... face receptors CTLA-4 and CD28

@ast

Both extracellular immunoglobi ...... face receptors CTLA-4 and CD28

@en

Both extracellular immunoglobi ...... face receptors CTLA-4 and CD28

@nl

prefLabel

Both extracellular immunoglobi ...... face receptors CTLA-4 and CD28

@ast

Both extracellular immunoglobi ...... face receptors CTLA-4 and CD28

@en

Both extracellular immunoglobi ...... face receptors CTLA-4 and CD28

@nl

P1433

Q28288428-A00C8835-AB6A-4EE1-8330-8372A525DE7B

P1476

Q28288428-3CE24467-FB17-4E9D-BFE7-3911D74FD73B

P2093

Q28288428-047119C0-9EED-4E9C-A4B3-2686CBAB3E9D

Q28288428-72119C18-375E-40D8-833C-2A5204EA2B36

Q28288428-8062E055-F7DA-4932-9018-B12822B9B41D

Q28288428-D2416FD3-39B5-4993-ABBE-E181CC025AFC

Q28288428-D2C3AB97-B735-4B13-9B24-3D9D4BDAB2C0

Q28288428-DE1FD657-52F5-47EE-8994-8818339B39B4

Q28288428-FE9F3527-7816-4381-B2D6-E22F9A5CE086

P2860

Q28288428-02A0DEFF-8FBB-4D80-AF2E-A40146721CED

Q28288428-03D8508B-90F3-401E-B0A8-F0C70032B898

Q28288428-03FD1826-FEE7-4431-B434-911B4038A7AD

Q28288428-09F1B318-6C97-4372-A62B-A7C4B700D2E9

Q28288428-0A39BE69-92F9-4124-8F64-F2C9E9DB576A

Q28288428-1102E7EF-4AD5-424F-9FD3-1AB17A84E458

Q28288428-176E31EE-C9D7-4D23-AFBB-2F226220BAF7

Q28288428-203C89E3-C490-4FFF-93D3-6A9F44499E36

Q28288428-27989572-A4AD-4E1F-A999-80402AF6EDC1

Q28288428-304E645A-CF2B-4F05-BDE7-D640EEAAB522

P304

Q28288428-336B0EE5-57D0-4E84-A179-DECC7FB913EC

P31

Q28288428-2E359102-54F3-49F7-85DD-237663EFB34E

P356

Q28288428-1F47AC72-0C8E-4EBA-B401-1E55A0075D50

P407

Q28288428-99FEA6FE-8DC8-4431-94CD-8C2F9E24221D

P433

Q28288428-C9293634-08C0-4C04-94EC-B303C2D7AB01

P478

Q28288428-0E7B1474-B182-41B3-9A41-6E693424E0E0

P577

Q28288428-9B031524-9568-4D16-9E1A-AFA41ABE1BE3

P5875

Q28288428-FB8D50A6-CF27-4673-A9C9-3757B65D82F1

P698

Q28288428-0F8B4DB8-2C12-4FA7-8A93-9E40AD45CD6E

P356

JBC.270.36.21181

P1433

Journal of Biological Chemistry

P1476

Both extracellular immunoglobi ...... face receptors CTLA-4 and CD28

@en

P2093

A Aruffo

http://www.w3.org/2001/XMLSchema#string

G Leytze

http://www.w3.org/2001/XMLSchema#string

J Bajorath

http://www.w3.org/2001/XMLSchema#string

J Greene

http://www.w3.org/2001/XMLSchema#string

J Naemura

http://www.w3.org/2001/XMLSchema#string

P S Linsley

http://www.w3.org/2001/XMLSchema#string

R J Peach

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation

Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7

Knowledge-based model building of proteins: concepts and examples

Crystal structure of the extracellular region of human tissue factor

Crystal structure of domains 3 and 4 of rat CD4: relation to the NH2-terminal domains

Site-directed mutagenesis by overlap extension using the polymerase chain reaction

Genomic organization and chromosomal location of the human gene encoding the B-lymphocyte activation antigen B7

CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones

The immunoglobulin fold. Structural classification, sequence patterns and common core

Many of the immunoglobulin superfamily domains in cell adhesion molecules and surface receptors belong to a new structural set which is close to that containing variable domains

P304

21181-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.270.36.21181

http://www.w3.org/2001/XMLSchema#string

P407

P433

36

http://www.w3.org/2001/XMLSchema#string

P478

270

http://www.w3.org/2001/XMLSchema#string

P577

1995-09-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

15652782

http://www.w3.org/2001/XMLSchema#string

P698

7545666

http://www.w3.org/2001/XMLSchema#string